{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:22:49Z","timestamp":1793996569795,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Peking University International Hospital Research Funds","award":["YN2023ZD03"],"award-info":[{"award-number":["YN2023ZD03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>While venous thromboembolism (VTE) prophylaxis is crucial following major orthopaedic surgeries including total knee arthroplasty (TKA), the impact of different prophylactic agents on postoperative hemoglobin (Hb) levels remains inadequately studied. The aim of this study was to compare the effects of aspirin, rivaroxaban, and low-molecular-weight heparin (LMWH) on early postoperative Hb changes following TKA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this single-center retrospective cohort study, 655 primary TKAs were finally included using data from the hospital information system. Patients received either aspirin, rivaroxaban, or LMWH for VTE prophylaxis. The primary outcome was the magnitude of Hb reduction, calculated as the difference between the Hb level on the first postoperative day and the minimum postoperative Hb level before discharge. The secondary outcome was the trajectory of postoperative Hb changes within the first week.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Postoperative Hb levels clearly declined within the first week, with a mean of 13.9\u00a0g\/L (<jats:italic>SD<\/jats:italic>, 8.5) from postoperative day 1 in the entire cohort. In the fully adjusted linear regression model, both rivaroxaban (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20091.5, [95%<jats:italic>CI<\/jats:italic>, 0.0 to 3.0]) and low-molecular-weight heparin (LMWH) (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20093.3, [95%<jats:italic>CI<\/jats:italic>, 1.5 to 5.2]) were associated with a greater reduction in Hb compared to aspirin. Regarding the trajectory of postoperative Hb changes, the generalized additive mixed model revealed no statistically significant difference between rivaroxaban and aspirin (<jats:italic>\u03b2<\/jats:italic> = -0.2, [95%<jats:italic>CI<\/jats:italic>, -0.6 to 0.2]). LMWH was associated with a greater daily reduction in Hb levels relative to aspirin, averaging 0.8\u00a0g\/L per day (<jats:italic>\u03b2<\/jats:italic> = -0.8, [95%<jats:italic>CI<\/jats:italic>, -1.3 to -0.3]). Despite these observed differences, the effect sizes were small, suggesting a lack of clinical significance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Hemoglobin levels declined significantly following TKA within the first week after surgery. However, no clinically meaningful distinction is discernible between the three most frequently used pharmacological agents, aspirin, rivaroxaban and LMWH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Level of evidence<\/jats:title>\n            <jats:p>III, A retrospective cohort study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13018-025-06004-7","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:28:13Z","timestamp":1750055293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of VTE prophylaxis agents on hemoglobin levels after total knee arthroplasty: a hospital information system-based observational study"],"prefix":"10.1186","volume":"20","author":[{"given":"Liang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Pizzigallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gumina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"9952","key":"6004_CR1","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/S0140-6736(14)60419-0","volume":"384","author":"AD Liddle","year":"2014","unstructured":"Liddle AD, Judge A, Pandit H, Murray DW. Adverse outcomes after total and unicompartmental knee replacement in 101\u2008330 matched patients: a study of data from the National Joint Registry for England and Wales. Lancet. 2014;384(9952):1437\u201345.","journal-title":"Lancet"},{"issue":"10","key":"6004_CR2","first-page":"1314","volume":"58","author":"N Maffulli","year":"2022","unstructured":"Maffulli N, Aicale R. Proximal femoral fractures in the elderly: a few things to know, and some to forget. Med (Kaunas). 2022;58(10):1314.","journal-title":"Med (Kaunas)"},{"issue":"8","key":"6004_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1056\/NEJMe1716534","volume":"378","author":"D Garcia","year":"2018","unstructured":"Garcia D. Hybrid strategy to prevent venous thromboembolism after joint arthroplasty. N Engl J Med. 2018;378(8):762\u20133.","journal-title":"N Engl J Med"},{"issue":"1","key":"6004_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10195-023-00742-2","volume":"25","author":"F Migliorini","year":"2024","unstructured":"Migliorini F, Maffulli N, Velaj E, Bell A, K\u00e4mmer D, Hildebrand F, et al. Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis. J Orthop Traumatol. 2024;25(1):1.","journal-title":"J Orthop Traumatol"},{"issue":"6","key":"6004_CR5","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s00590-024-04071-w","volume":"34","author":"F Migliorini","year":"2024","unstructured":"Migliorini F, Maffulli N, Velaj E, Bell A, K\u00e4mmer D, Eschweiler J, et al. Antithrombotic prophylaxis following total knee arthroplasty: a level I Bayesian network meta-analysis. Eur J Orthop Surg Traumatol. 2024;34(6):2881\u201390.","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"4","key":"6004_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.surge.2021.03.004","volume":"20","author":"F Migliorini","year":"2022","unstructured":"Migliorini F, Maffulli N, Eschweiler J, Knobe M, Tingart M, Betsch M. Tourniquet use during knee arthroplasty: a Bayesian network meta-analysis on pain, function, and thromboembolism. Surgeon. 2022;20(4):241\u201351.","journal-title":"Surgeon"},{"issue":"9691","key":"6004_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(09)61551-8","volume":"374","author":"UG Longo","year":"2009","unstructured":"Longo UG, Maffulli N, Denaro V. Rivaroxaban versus enoxaparin after total knee arthroplasty. Lancet. 2009;374(9691):681\u20132.","journal-title":"Lancet"},{"issue":"11","key":"6004_CR8","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/14740338.2024.2411380","volume":"23","author":"F Migliorini","year":"2024","unstructured":"Migliorini F, Maffulli N. What are the best antithrombotic prophylaxes following total knee arthroplasty? Expert Opin Drug Saf. 2024;23(11):1367\u20139.","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"6004_CR9","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1007\/s00167-023-07500-1","volume":"31","author":"P Za","year":"2023","unstructured":"Za P, Papalia GF, Franceschetti E, Rizzello G, Adravanti P, Papalia R. Aspirin is a safe and effective thromboembolic prophylaxis after total knee arthroplasty: a systematic review and meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2023;31(10):4407\u201321.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"7","key":"6004_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1097\/CORR.0000000000002544","volume":"481","author":"VS Sidhu","year":"2023","unstructured":"Sidhu VS, Naylor JM, Adie S, Lieu D, Walker R, Horsley M, et al. Is enoxaparin associated with a higher risk of persistent wound drainage than aspirin?? A secondary analysis of data from the CRISTAL randomized trial. Clin Orthop Relat Res. 2023;481(7):1351\u20139.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"6004_CR11","first-page":"200","volume":"107","author":"NS Kulkarni","year":"2023","unstructured":"Kulkarni NS. Enoxaparin is better than aspirin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Am Fam Physician. 2023;107(2):200\u20131.","journal-title":"Am Fam Physician"},{"issue":"2","key":"6004_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00590-018-2307-7","volume":"29","author":"PK Karampinas","year":"2019","unstructured":"Karampinas PK, Megaloikonomos PD, Lampropoulou-Adamidou K, Papadelis EG, Mavrogenis AF, Vlamis JA, et al. Similar thromboprophylaxis with rivaroxaban and low molecular weight heparin but fewer hemorrhagic complications with combined intra-articular and intravenous tranexamic acid in total knee arthroplasty. Eur J Orthop Surg Traumatol. 2019;29(2):455\u201360.","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"40","key":"6004_CR13","doi-asserted-by":"publisher","first-page":"e12630","DOI":"10.1097\/MD.0000000000012630","volume":"97","author":"YM Zhang","year":"2018","unstructured":"Zhang YM, Liu JY, Sun XD, Zhang M, Liu XG, Chen XL. Rivaroxaban improves hidden blood loss, blood transfusion rate and reduces swelling of the knee joint in knee osteoarthritis patients after total knee replacement. Med (Baltim). 2018;97(40):e12630.","journal-title":"Med (Baltim)"},{"issue":"2","key":"6004_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/CM9.0000000000001305","volume":"134","author":"Y Ren","year":"2021","unstructured":"Ren Y, Cao SL, Li Z, Luo T, Feng B, Weng XS. Comparable efficacy of 100\u00a0mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial. Chin Med J (Engl). 2021;134(2):164\u201372.","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"6004_CR15","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.arth.2023.02.021","volume":"38","author":"G Singh","year":"2023","unstructured":"Singh G, Prentice HA, Winston BA, Kroger EW. Comparison of 90-day adverse events associated with aspirin and potent anticoagulation use for venous thromboembolism prophylaxis: a cohort study of 72,288 total knee and 35,142 total hip arthroplasty patients. J Arthroplasty. 2023;38(8):1602\u2013e16121.","journal-title":"J Arthroplasty"},{"issue":"16","key":"6004_CR16","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.2106\/JBJS.20.02250","volume":"103","author":"JR Lieberman","year":"2021","unstructured":"Lieberman JR, Bell JA. Venous thromboembolic prophylaxis after total hip and knee arthroplasty. J Bone Joint Surg Am. 2021;103(16):1556\u201364.","journal-title":"J Bone Joint Surg Am"},{"issue":"12","key":"6004_CR17","doi-asserted-by":"publisher","first-page":"e2345883","DOI":"10.1001\/jamanetworkopen.2023.45883","volume":"6","author":"SJ Simon","year":"2023","unstructured":"Simon SJ, Patell R, Zwicker JI, Kazi DS, Hollenbeck BL. Venous thromboembolism in total hip and total knee arthroplasty. JAMA Netw Open. 2023;6(12):e2345883.","journal-title":"JAMA Netw Open"},{"key":"6004_CR18","doi-asserted-by":"crossref","unstructured":"Bartlett MA, Mauck KF, Stephenson CR, Ganesh R, Daniels PR. Perioperative venous thromboembolism prophylaxis. Mayo Clin Proc. 2020;95(12):2775\u201398.","DOI":"10.1016\/j.mayocp.2020.06.015"},{"issue":"9","key":"6004_CR19","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s11999-017-5394-6","volume":"475","author":"A Bala","year":"2017","unstructured":"Bala A, Huddleston JI, Goodman SB, Maloney WJ, Amanatullah DF. Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors? Clin Orthop Relat Res. 2017;475(9):2205\u201313.","journal-title":"Clin Orthop Relat Res"},{"key":"6004_CR20","unstructured":"Piple AS, Wang JC, Kang HP, Mills ES, Mayfield CK, Lieberman JR et al. Safety and efficacy of rivaroxaban in primary total hip and knee arthroplasty. J Arthroplasty. 2023;S0883-5403(23)00137-7."},{"issue":"1","key":"6004_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1186\/s13018-024-05357-9","volume":"19","author":"X Li","year":"2024","unstructured":"Li X, Lai J, Yang X, Xu H, Xiang S. Intra-articular injection of vancomycin after arthrotomy closure following gentamicin-impregnated bone cementation in primary total knee arthroplasty provides a high intra-articular concentration while avoiding systemic toxicity: a prospective study. J Orthop Surg Res. 2024;19(1):856.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6004_CR22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1186\/s13018-024-05324-4","volume":"19","author":"C Zhao","year":"2024","unstructured":"Zhao C, Liao Q, Yang D, Yang M, Xu P. Advances in perioperative pain management for total knee arthroplasty: a review of multimodal analgesic approaches. J Orthop Surg Res. 2024;19(1):843.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6004_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1186\/s13018-024-05194-w","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu Y, Xing Z, Wu B, Chen N, Wu T, Cai Z, et al. Association of MRI-based knee osteoarthritis structural phenotypes with short-term structural progression and subsequent total knee replacement. J Orthop Surg Res. 2024;19(1):699.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6004_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1186\/s13018-024-05372-w","volume":"19","author":"P Xing","year":"2024","unstructured":"Xing P, Qu J, Feng S, Guo J, Huang T. Comparison of the efficacy of robot-assisted total knee arthroplasty in patients with knee osteoarthritis with varying severity deformity. J Orthop Surg Res. 2024;19(1):872.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6004_CR25","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1186\/s13018-024-05273-y","volume":"19","author":"J Yang","year":"2024","unstructured":"Yang J, Li X, Liu P, Liu X, Li L, Zhang M. The impact of patellofemoral joint diseases on functional outcomes and prosthesis survival in patients undergoing unicompartmental knee arthroplasty: a systematic review and meta-analysis. J Orthop Surg Res. 2024;19(1):840.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6004_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s43019-021-00100-8","volume":"33","author":"S Thiengwittayaporn","year":"2021","unstructured":"Thiengwittayaporn S, Budhiparama N, Tanavalee C, Tantavisut S, Sorial RM, Li C, et al. Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: part 3. Pharmacological venous thromboembolism prophylaxis. Knee Surg Relat Res. 2021;33(1):24.","journal-title":"Knee Surg Relat Res"},{"key":"6004_CR27","doi-asserted-by":"publisher","unstructured":"Quinlan DJ, Eikelboom JW, Douketis JD. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. In: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2002. p. CD004179. Available from: https:\/\/doi.org\/10.1002\/14651858.CD004179","DOI":"10.1002\/14651858.CD004179"},{"issue":"2","key":"6004_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s13167-020-00208-z","volume":"11","author":"X Zhao","year":"2020","unstructured":"Zhao X, Wang K, Zuo P, Liu Y, Zhang M, Xie S, et al. Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients\u2014indications for predictive, preventive, and personalized medical approach. EPMA J. 2020;11(2):139\u201345.","journal-title":"EPMA J"},{"issue":"3","key":"6004_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/archpsyc.61.3.310","volume":"61","author":"R Gueorguieva","year":"2004","unstructured":"Gueorguieva R, Krystal JH. Move Over ANOVA. Arch Gen Psychiatry. 2004;61(3):310.","journal-title":"Arch Gen Psychiatry"},{"issue":"14","key":"6004_CR30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jacc.2007.10.065","volume":"51","author":"SS Najjar","year":"2008","unstructured":"Najjar SS, Scuteri A, Shetty V, Wright JG, Muller DC, Fleg JL, et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore longitudinal study of aging. J Am Coll Cardiol. 2008;51(14):1377\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6004_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med"},{"key":"6004_CR32","doi-asserted-by":"crossref","unstructured":"Su YS, Gelman A, Hill J, Yajima M. Multiple imputation with diagnostics (mi) inR: opening windows into the black box. J Stat Softw. 2011;45(2). Available from: http:\/\/www.jstatsoft.org\/v45\/i02\/","DOI":"10.18637\/jss.v045.i02"},{"issue":"5","key":"6004_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1001\/jama.2022.11390","volume":"328","author":"E Cipolletta","year":"2022","unstructured":"Cipolletta E, Tata LJ, Nakafero G, Avery AJ, Mamas MA, Abhishek A. Association between gout flare and subsequent cardiovascular events among patients with gout. JAMA. 2022;328(5):440.","journal-title":"JAMA"},{"issue":"1","key":"6004_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11999-012-2488-z","volume":"471","author":"BP Gillette","year":"2013","unstructured":"Gillette BP, DeSimone LJ, Trousdale RT, Pagnano MW, Sierra RJ. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res. 2013;471(1):150\u20134.","journal-title":"Clin Orthop Relat Res"},{"issue":"10","key":"6004_CR35","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1302\/0301-620X.105B10.BJJ-2023-0030.R2","volume":"105\u2013B","author":"DA Kolin","year":"2023","unstructured":"Kolin DA, Sculco PK, Gonzalez Della Valle A, Rodriguez JA, Ast MP, Chalmers BP. Risk factors for blood transfusion and postoperative anaemia following total knee arthroplasty. Bone Joint J. 2023;105\u2013B(10):1086\u201393.","journal-title":"Bone Joint J"},{"issue":"7","key":"6004_CR36","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.arth.2023.01.018","volume":"38","author":"DA Kolin","year":"2023","unstructured":"Kolin DA, Lyman S, Della Valle AG, Ast MP, Landy DC, Chalmers BP. Predicting postoperative anemia and blood transfusion following total knee arthroplasty. J Arthroplasty. 2023;38(7):1262\u2013e12662.","journal-title":"J Arthroplasty"},{"issue":"1","key":"6004_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jcma.2018.08.002","volume":"82","author":"CF Chen","year":"2019","unstructured":"Chen CF, Tsai SW, Wu PK, Chen CM, Chen WM. Does continued aspirin mono-therapy lead to a higher bleeding risk after total knee arthroplasty? J Chin Med Assoc. 2019;82(1):60\u20135.","journal-title":"J Chin Med Assoc"},{"issue":"Pt A","key":"6004_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ijsu.2018.04.059","volume":"54","author":"ZN Xia","year":"2018","unstructured":"Xia ZN, Zhou Q, Zhu W, Weng XS. Low molecular weight heparin for the prevention of deep venous thrombosis after total knee arthroplasty: a systematic review and meta-analysis. Int J Surg. 2018;54(Pt A):265\u201375.","journal-title":"Int J Surg"},{"issue":"1","key":"6004_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2106\/00004623-200701000-00005","volume":"89","author":"VP Patel","year":"2007","unstructured":"Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89(1):33\u20138.","journal-title":"J Bone Joint Surg Am"},{"issue":"9","key":"6004_CR40","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1111\/j.1538-7836.2011.04432.x","volume":"9","author":"M LEVI","year":"2011","unstructured":"LEVI M, KAMPHUISEN EERENBERGE. Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. J Thromb Haemost. 2011;9(9):1705\u201312.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"6004_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1302\/0301-620X.86B4.14508","volume":"86\u2013B","author":"KR Sehat","year":"2004","unstructured":"Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. J Bone Joint Surg Br. 2004;86\u2013B(4):561\u20135.","journal-title":"J Bone Joint Surg Br"},{"issue":"21","key":"6004_CR42","first-page":"3030","volume":"123","author":"FJ Zhang","year":"2010","unstructured":"Zhang FJ, Xiao Y, Liu YB, Tian X, Gao ZG. Clinical effects of applying a tourniquet in total knee arthroplasty on blood loss. Chin Med J (Engl). 2010;123(21):3030\u20133.","journal-title":"Chin Med J (Engl)"},{"key":"6004_CR43","doi-asserted-by":"crossref","unstructured":"Zhang Y, Li Z, jun, Zheng Y fa, Feng Sqing, Li H. Delayed drainage versus autotransfusion drainage and routine drainage after total knee arthroplasty: a comparative study. J Orthop Surg Res. 2013;8(1):39.","DOI":"10.1186\/1749-799X-8-39"},{"issue":"1","key":"6004_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.arth.2017.07.034","volume":"33","author":"IS Lindman","year":"2018","unstructured":"Lindman IS, Carlsson LV. Extremely low transfusion rates: contemporary primary total hip and knee arthroplasties. J Arthroplasty. 2018;33(1):51\u20134.","journal-title":"J Arthroplasty"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06004-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-06004-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06004-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:28:15Z","timestamp":1750055295000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-025-06004-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6004"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-06004-7","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional research ethics board of Peking University International Hospital (No. 2023-KY-0044-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"589"}}